Do high sensitivity cardiac troponin assays improve patient outcomes?

Authors/Creators

Abadi K. Gebre, Edith Cowan UniversityFollow
Marc Sim, Edith Cowan UniversityFollow
Carl Schultz

Abstract

Cardiac troponins have replaced other blood biomarkers for the diagnosis of myocardial injury. They are widely used to risk stratify patients towards safe early discharge or further investigation of coronary anatomy when clinical and electrocardiographic features are suggestive of acute coronary syndrome. ...

RAS ID

62361

Document Type

Editorial

Date of Publication

1-1-2023

PubMed ID

38011934

School

School of Medical and Health Sciences / Nutrition and Health Innovation Research Institute

Copyright

free_to_read

Publisher

BMJ Publishing Group

Comments

Gebre, A. K., Sim, M., & Schultz, C. (2023). Do high sensitivity cardiac troponin assays improve patient outcomes? [Editorial]. The BMJ, 383, 1-2. https://doi.org/10.1136/bmj.p2741

Recommended Citation

Gebre, A. K., Sim, M., & Schultz, C. (2023). Do high sensitivity cardiac troponin assays improve patient outcomes?. DOI: https://doi.org/10.1136/bmj.p2741